Leo Ehrlich

This is a page dedicated to get more information for investors to evaluate the management style of Leo Ehrlich who is a Chief Financial Officer of Nanoviricides, Inc.

Here on this page we are inviting all readers to discuss Leo Ehrlich. You may anonymously post comments with any information that they have about Leo Ehrlich. You can post comments about their management style or whatever you want to talk about concerning their ability as an executive. Please refrain from personal attacks.

Here is a copy of personal Bio that we found:

Mr. Leo Ehrlich was appointed to the Board of Directors in September 1999. Prior to joining the Company, he was president of Immmu Inc., a privately held vitamin company from January 1998 to September 1999. He is also the CFO and a director of NanoViricides, Inc. (NNVC), a pharmaceutical company developing targeted anti-viral drugs. He is a Certified Public Accountant and received his BBA from Bernard Baruch College of the City University of New York.